Deficiency of a novel retinoblastoma binding protein 2-homolog is a consistent feature of sporadic human melanoma skin cancer.

Laboratory Investigation; a Journal of Technical …, 1999 - europepmc.org
Using RNA arbitrarily primed PCR, the authors selected for transcripts with cell cycle-related
differential expression in cultured human melanocytes. Among the partial cDNAs cloned, a …

[引用][C] Deficiency of a novel retinoblastoma binding protein 2-homolog is a consistent feature of sporadic human melanoma skin cancer

T VOGT - Lab Invest, 1999 - cir.nii.ac.jp
Deficiency of a novel retinoblastoma binding protein 2-homolog is a consistent feature of
sporadic human melanoma skin cancer | CiNii Research CiNii 国立情報学研究所 学術情報 …

[引用][C] Deficiency of a novel retinoblastoma binding protein 2-homolog is a consistent feature of sporadic human melanoma skin cancer

T VOGT, M KROISS, M MCCLELLAND… - Laboratory …, 1999 - pascal-francis.inist.fr
Deficiency of a novel retinoblastoma binding protein 2-homolog is a consistent feature of
sporadic human melanoma skin cancer CNRS Inist Pascal-Francis CNRS Pascal and …

Deficiency of a novel retinoblastoma binding protein 2-homolog is a consistent feature of sporadic human melanoma skin cancer

T Vogt, M Kroiss, M McClelland… - … ; a journal of …, 1999 - pubmed.ncbi.nlm.nih.gov
Using RNA arbitrarily primed PCR, the authors selected for transcripts with cell cycle-related
differential expression in cultured human melanocytes. Among the partial cDNAs cloned, a …

[引用][C] Deficiency of a novel retinoblastoma binding protein 2-homolog is a consistent feature of sporadic human melanoma skin cancer

T VOGT, M KROISS, M MCCLELLAND… - Laboratory …, 1999 - Nature Publishing Group